Alerts will be sent to your verified email
Verify Email
JAGSNPHARM
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Jagsonpal Pharmaceutical, founded in 1964, specializes in research, development, manufacturing, and distribution of bulk drugs and pharmaceutical formulations globally, aiming to establish a strong presence in the industry.
Jagsonpal Pharma major competitors are Syncom Formulations, Bliss GVS Pharma, Beta Drugs, Venus Remedies, Lincoln Pharma, Kwality Pharma, Novartis.
Market Cap of Jagsonpal Pharma is ₹1,439 Crs.
While the median market cap of its peers are ₹1,444 Crs.
Jagsonpal Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jul Nov | Mar Jun Sep Dec | Jan Mar Jun Sep | Jun Sep Dec | ||||||||||||||
| Investor Presentation | Mar May Jul Nov | Mar Jun Sep Dec | Jan Mar Jun Sep Dec | Feb Jun Sep Dec | Dec | |||||||||||||
| Conference Call | Mar Jun Nov | Sep Dec | ||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
